Ipilimumab



Indications and Reactions:

Role Indications Reactions
Primary
Malignant Melanoma 63.3%
Metastatic Malignant Melanoma 9.5%
Pain 3.5%
Nausea 3.0%
Prostate Cancer 3.0%
Small Cell Lung Cancer Stage Unspecified 2.0%
Prophylaxis 1.9%
Diarrhoea 1.8%
Lung Neoplasm Malignant 1.7%
Hypertension 1.5%
Anxiety 1.4%
Constipation 1.2%
Non-small Cell Lung Cancer 1.2%
Insomnia 1.0%
Premedication 0.8%
Vomiting 0.8%
Depression 0.7%
Atrial Fibrillation 0.6%
Hypersensitivity 0.6%
Medical Diet 0.6%
Diarrhoea 13.4%
Vomiting 11.1%
Pyrexia 10.7%
Colitis 6.5%
Dehydration 5.8%
Neoplasm Malignant 5.4%
Nausea 4.9%
Sepsis 3.9%
Malignant Neoplasm Progression 3.8%
Abdominal Pain 3.6%
Lipase Increased 3.6%
Headache 3.5%
Anaemia 3.2%
Death 3.2%
Renal Failure Acute 3.2%
Hyponatraemia 3.1%
Hypophysitis 2.9%
Pain 2.9%
Fatigue 2.6%
Thrombocytopenia 2.6%
Secondary
Malignant Melanoma 36.0%
Product Used For Unknown Indication 35.2%
Metastatic Malignant Melanoma 5.6%
Drug Use For Unknown Indication 5.0%
Diarrhoea 3.0%
Prostate Cancer 2.2%
Pain 2.0%
Non-small Cell Lung Cancer 1.9%
Prostate Cancer Metastatic 1.8%
Back Pain 1.0%
Constipation 0.9%
Hypertension 0.8%
Nausea 0.6%
Peripheral Arterial Occlusive Disease 0.6%
Depression 0.6%
Diabetes Mellitus 0.6%
Prophylaxis 0.6%
Vitamin Supplementation 0.6%
Anxiety 0.5%
Convulsion 0.5%
Vomiting 11.3%
Joint Range Of Motion Decreased 7.0%
Colitis 6.3%
Pulmonary Embolism 5.6%
Weight Decreased 5.6%
Pneumonitis 4.9%
Pyrexia 4.9%
Rash 4.9%
Sepsis 4.9%
Urinary Tract Infection 4.9%
Alanine Aminotransferase Increased 4.2%
Atrial Fibrillation 4.2%
Diarrhoea 4.2%
Hypotension 4.2%
Neoplasm Malignant 4.2%
Swelling 4.2%
Fatigue 3.5%
Lipase Increased 3.5%
Rash Maculo-papular 3.5%
Temporal Arteritis 3.5%
Concomitant
Metastatic Malignant Melanoma 26.0%
Product Used For Unknown Indication 18.3%
Malignant Melanoma 12.2%
Acute Lymphocytic Leukaemia 8.4%
Epilepsy 3.8%
Pain 3.8%
Colitis 3.1%
Multiple Myeloma 3.1%
Prostate Cancer 3.1%
Brain Oedema 2.3%
Neoplasm Malignant 2.3%
Prostate Cancer Metastatic 2.3%
Back Pain 1.5%
Depression 1.5%
Melanoma 1.5%
Melanoma Recurrent 1.5%
Metastasis 1.5%
Oedema 1.5%
Tumour Associated Fever 1.5%
Deep Vein Thrombosis 0.8%
Pyrexia 13.8%
Angina Unstable 10.3%
Death 10.3%
Malignant Melanoma 10.3%
Adenocarcinoma Pancreas 3.4%
Adrenocortical Insufficiency Acute 3.4%
Blood Creatinine Increased 3.4%
Chills 3.4%
Colitis 3.4%
Decreased Appetite 3.4%
Disease Progression 3.4%
Drug Ineffective 3.4%
Ecg Signs Of Myocardial Ischaemia 3.4%
Heart Rate Increased 3.4%
Hyperkeratosis 3.4%
Hypopituitarism 3.4%
Jaundice 3.4%
Metastases To Bladder 3.4%
Metastases To Central Nervous System 3.4%
Nephritis Autoimmune 3.4%
Interacting
Malignant Melanoma 100.0%
Rash Maculo-papular 100.0%